BIONTECH SE - AMERICAN

BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD

19 Jul 2021 08:00:00 By Nasdaq GlobeNewswire

BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma

18 Jun 2021 05:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations

10 Jun 2021 02:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents

28 May 2021 15:45:00 By Nasdaq GlobeNewswire

BioNTech Publishes First Sustainability Report and Receives “Prime” Rating by ISS ESG

21 May 2021 06:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine

20 May 2021 06:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®

20 May 2021 05:00:00 By Nasdaq GlobeNewswire

BioNTech Broadens Management Board by Appointing Jens Holstein as CFO

18 May 2021 06:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents

11 May 2021 02:30:00 By Nasdaq GlobeNewswire

BioNTech Announces First Quarter 2021 Financial Results and Corporate Update

10 May 2021 07:00:00 By Nasdaq GlobeNewswire

BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore

10 May 2021 01:31:52 By Nasdaq GlobeNewswire

Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine

07 May 2021 06:45:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games

06 May 2021 06:30:00 By Nasdaq GlobeNewswire

BioNTech to Report First Quarter 2021 Financial Results and Operational Update on May 10, 2021

04 May 2021 07:02:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents

30 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®

19 Apr 2021 04:00:00 By Nasdaq GlobeNewswire

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

01 Apr 2021 06:45:00 By Nasdaq GlobeNewswire

Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents

31 Mar 2021 06:45:00 By Nasdaq GlobeNewswire

BioNTech Announces Full Year 2020 Financial Results and Corporate Update

30 Mar 2021 06:30:00 By Nasdaq GlobeNewswire

BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

26 Mar 2021 09:45:00 By Nasdaq GlobeNewswire